The solubilization and biological activities of Aspergillus β-(1→3)-D-glucan

被引:43
|
作者
Ishibashi, K
Miura, NN
Adachi, Y
Tamura, H
Tanaka, S
Ohno, N
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Immunopathol Lab, Hachioji, Tokyo 1920392, Japan
[2] Seikagaku Corp, Tokyo Res Inst, Tokyo 207, Japan
来源
关键词
Aspergillus solubilized beta-glucan; limulus activity; fungal infection;
D O I
10.1016/j.femsim.2004.04.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have recently demonstrated that the cell wall P-glucan of Candida albicans could be solubilized by sodium hypochlorite, followed by dimethylsulfoxide-extraction (NaClO-DMSO method). In this study, applying this method to Aspergillus spp., we prepared mycelial cell wall P-glucan and examined its physical properties and immuno toxicological activity. The acetone-dried mycelia of Aspergillus spp. were oxidized by the NaClO-DMSO method. An analysis of C-13 NMR spectra revealed the preparations to be composed of alpha-(1 --> 3) and beta-(1 --> 3)-D-glucan. Also, the proportion of alpha-(1 --> 3) and beta-(1 --> 3)-D-glucan varied. Futhermore, a solubilized Aspergillus beta-glucan (ASBG) was prepared from OX-Asp by urea-autocalve treatment. ASBG showed limulus activity similar to Candida solubilized beta-glucan (CSBG), and there was little difference in the activity of ASBG between various Aspergillus spp. ASBG affected the production of IL-8 by human peripheral blood mononuclear cells (PBMC). ASBG should be useful for analyzing the clinical role of beta-glucan. (C) 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 50 条
  • [1] Interference of (1→3)-β-D-glucan Administration in the Measurement of Plasma (1→3)-β-D-glucan
    Ishizuka, Y
    Tsukada, H
    Gejyo, F
    [J]. INTERNAL MEDICINE, 2004, 43 (02) : 97 - 101
  • [2] Preparation, structural analysis and antioxidant activities of phosphorylated (1 → 3)-β-D-glucan
    Mei, Xinya
    Tang, Qilin
    Huang, Gangliang
    Long, Rong
    Huang, Hualiang
    [J]. FOOD CHEMISTRY, 2020, 309
  • [3] Overview of (1→3)-β-D-glucan immunobiology
    Williams, DL
    [J]. MEDIATORS OF INFLAMMATION, 1997, 6 (04) : 247 - 250
  • [4] (1→3) β-D-Glucan as a Prognostic Marker
    Chow, Harry
    Hurley, James C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : 466 - 466
  • [5] Inhalation of (1→3)-β-D-glucan in humans
    Beijer, L
    Thorn, J
    Rylander, R
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A856 - A856
  • [6] Effects of microfluidization with ionic liquids on the solubilization and structure of β-D-glucan
    Liu, Hongzhi
    Li, Yanan
    Gao, Jie
    Shi, Aimin
    Liu, Li
    Hu, Hui
    Putri, Novita
    Yu, Hongwei
    Fan, Wei
    Wang, Qiang
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 84 : 394 - 401
  • [7] Water Solubilization of Fullerene Derivatives by β-(1,3-1,6)-D-Glucan and Their Photodynamic Activities toward Macrophages
    Ikeda, Atsushi
    Iizuka, Tatsuya
    Maekubo, Naotake
    Nobusawa, Kazuyuki
    Sugikawa, Kouta
    Koumoto, Kazuya
    Suzuki, Toshio
    Nagasaki, Takeshi
    Akiyama, Motofusa
    [J]. CHEMISTRY-AN ASIAN JOURNAL, 2017, 12 (10) : 1069 - 1074
  • [8] Pharmacokinetics, biological effects, and distribution of (1→3)-β-D-glucan in blood and organs in rabbits
    Yoshida, M
    Roth, RI
    Grunfeld, C
    Feingold, KR
    Levin, J
    [J]. MEDIATORS OF INFLAMMATION, 1997, 6 (04) : 279 - 283
  • [9] Structural stability of (1→3)-β-D-glucan macrocycles
    Falch, BH
    Stokke, BT
    [J]. CARBOHYDRATE POLYMERS, 2001, 44 (02) : 113 - 121
  • [10] (1→3)-β-D-Glucan kinetics in patients with candidemia
    Held, J.
    Grawitz, A. Busse
    Epting, T.
    Friedrich, R.
    Draeger, S.
    Rappold, E.
    [J]. MYCOSES, 2014, 57 : 16 - 17